Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fiasp vs NovoRapid Around Exercise in Type 1 Diabetes
DRKS00015855Phase 4Recruiting
- Sponsor
- Forschungseinheit für interdisziplinäre metabolische Medizin
- Start
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 4, randomised trial of human insulin and insulin aspart in diabetes mellitus type 1 (T1D) (4 arms), sponsored by Forschungseinheit für interdisziplinäre metabolische Medizin. Primary endpoint: Change in blood glucose around exercise. Started Jun 2019; status: recruiting.
02
Drugs
human insulininsulin aspart
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on DRKS00015855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00015855.